lunes, 22 de diciembre de 2025
EURORDIS welcomes the Commission’s ‘promising’ Biotech Act I December 2025
EURORDIS welcomes the Commission’s ‘promising’ Biotech Act I
December 2025
16 December 2025, Strasbourg – While EURORDIS–Rare Diseases Europe will take more time to analyse the European Commission’s Biotech Act I proposals in detail, we welcome this important step towards strengthening Europe’s capacity to innovate in health and translate scientific progress into tangible benefits for society.
https://www.eurordis.org/eurordis-welcomes-commissions-biotech-act-i/
There is No Drop-Dead Date for an ACA Tax Credit Extension, But Coverage Losses Will Mount as the Clock Ticks
https://www.kff.org/quick-take/there-is-no-drop-dead-date-for-an-aca-tax-credit-extension-but-coverage-losses-will-mount-as-the-clock-ticks/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-927xI3WG7ee7INSs2sWhiapU7sm9n-qYlBJnIPFM1DDog3GmV6ipeFlpCs9enowng484ee_OkhmDhsh-Rf0Vqao9TGWA&_hsmi=395312363&utm_content=395312363&utm_source=hs_email
A discharge petition in the House paves the way for a vote on a three-year extension of the tax credits, which would provide ACA enrollees premium relief whenever it comes. While there is still time to extend the enhanced tax credits, with each passing day, more and more ACA Marketplace enrollees are going to drop their health insurance when faced with eye-popping increases in their premium payments, writes KFF’s Larry Levitt.
Suscribirse a:
Comentarios (Atom)

